Evidence supporting the use of: Ginkgo Flavonglycosides
For the health condition: Arteriosclerosis

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Traditional
Rating (out of 5): 2

Ginkgo flavonglycosides, derived from the leaves of Ginkgo biloba, have a long history of use in traditional medicine systems, particularly in China, for various circulatory disorders. Their use for arteriosclerosis—commonly known as hardening of the arteries—primarily stems from this traditional context. Historically, Ginkgo extracts have been employed with the belief that they can improve blood flow, reduce symptoms associated with poor circulation, and support vascular health. However, when it comes to scientific evidence specifically addressing arteriosclerosis, the data is limited and largely indirect. Most clinical research on Ginkgo biloba focuses on cognitive function, peripheral vascular disease, and intermittent claudication, rather than a direct effect on arteriosclerotic plaque or arterial stiffness. Some laboratory and animal studies suggest that Ginkgo flavonglycosides possess antioxidant and anti-inflammatory properties, which could theoretically be beneficial in slowing the progression of arteriosclerotic changes. Nevertheless, high-quality human trials directly evaluating their effect on arteriosclerosis are lacking. As such, its use for this condition is justified more by traditional use and theoretical rationale than by rigorous scientific validation.

More about Ginkgo Flavonglycosides
More about Arteriosclerosis

Products containing Ginkgo Flavonglycosides

We currently have no products on Vitabase that contain this ingredient.